Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Composition comprising n-acetylcysteine and/or microencapsulated gastroprotected lysozyme in association with probiotic bacteria capable of restoring the stomach's own barrier effect which is lost during the pharmacological treatment of gastric hyperacidity

A technology for acetylcysteine ​​and hyperacidity, applied in the direction of drug combination, application, food science, etc., can solve problems such as patient exposure, achieve the effect of improving efficacy and minimizing drug intake

Inactive Publication Date: 2014-08-13
G·莫格纳
View PDF1 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

On the other hand, it is not even conceivable to continue drug therapy and expose patients to the risk of such infections

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Composition comprising n-acetylcysteine and/or microencapsulated gastroprotected lysozyme in association with probiotic bacteria capable of restoring the stomach's own barrier effect which is lost during the pharmacological treatment of gastric hyperacidity
  • Composition comprising n-acetylcysteine and/or microencapsulated gastroprotected lysozyme in association with probiotic bacteria capable of restoring the stomach's own barrier effect which is lost during the pharmacological treatment of gastric hyperacidity
  • Composition comprising n-acetylcysteine and/or microencapsulated gastroprotected lysozyme in association with probiotic bacteria capable of restoring the stomach's own barrier effect which is lost during the pharmacological treatment of gastric hyperacidity

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0034] The applicant has carried out intensive research and selective activities and finally found that a probiotic strain belonging to at least one species selected from the group comprising or alternatively consisting of the following strains is effective for use in the treatment of proton pump inhibitors ( PPI) to reduce or treat subjects with hyperacidity: Lactobacillus acidophilus (L.acidophilus), Lactobacillus crispatus (L.crispatus), Lactobacillus gasseri (L.gasseri), Lactobacillus delbrueckii (L. delbrueckii), L.delbr.subsp.delbrueckii, L.salivarius, L.casei, L.paracasei, plant L. plantarum, L. rhamnosus, L. reuteri, L. brevis, L. buchneri, fermentation L.fermentum, L.lactis, L.pentosus, B.adolescentis, B.angulatum, Bifidobacterium bifidum B.bifidum, B.breve, B.catenulatum, B.infantis, B.lactis, long Bifidobacterium longum, B. pseudocatenulatum and S. thermophilus. Furthermore, the applicant has found that, as a result of the presence of N-acetylcysteine ​​(NAC) in ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
melting pointaaaaaaaaaa
melting pointaaaaaaaaaa
Login to View More

Abstract

The present invention refers to a composition comprising N-acetylcysteine and / or lysozyme; or N-acetylcysteine and microencapsulated gastroprotected lysozyme with probiotic bacteria for use in the pharmacological treatment of gastric hyperacidity. Said composition is capable of restoring the stomach's own barrier effect, which is lost during the pharmacological treatment of gastric hyperacidity, and of minimising the secondary effects due to said pharmacological treatment.

Description

technical field [0001] The present invention relates to a composition comprising N-acetylcysteine ​​and / or lysozyme or N-acetylcysteine ​​and microencapsulated lysozyme in combination with probiotics for the medical treatment of hyperacidity. The composition is capable of restoring the barrier effect of the stomach itself lost during the drug treatment of hyperacidity and minimizing the side effects due to the drug treatment. Furthermore, the presence of N-acetylcysteine, preferably in non-microencapsulated form, in the composition is capable of increasing the efficacy of the probiotics used against pathogens, preferably the presence of microencapsulated and gastroprotective lysozyme Capable of combating excessive bacterial growth and inhibiting the germination of any Clostridium spores present without any type of inhibition involving the probiotic flora. Background technique [0002] Over the past few decades, various pharmacological approaches have been developed for the ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K35/74A61P1/04A61K35/741A61K35/744A61K35/745
CPCA61K38/47A61K35/745A61K31/198A61K35/747A61K45/06A61K35/744A61K35/74A23L1/3014A61K35/741A23L1/296A23L33/40A23L33/135A61P1/00Y02A50/30A61K2300/00
Inventor G·莫格纳
Owner G·莫格纳
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products